{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:51:40Z","timestamp":1784742700325,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:00:00Z","timestamp":1605830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:00:00Z","timestamp":1605830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Helsinki including Helsinki University Central Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose of review<\/jats:title>\n                <jats:p>Observational studies have shown that serum 25-OH vitamin D [25(OH)D] is inversely associated with overall cancer risk in many malignancies. We performed a systematic literature review to determine whether vitamin D deficiency is related to head and neck cancer (HNC) etiology and outcome.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Recent findings<\/jats:title>\n                <jats:p>The search yielded five prospective studies reporting 25(OH)D levels prior to cancer diagnosis and their effect on the risk of HNC. Eight studies were cross-sectional or case-control studies, in which 25(OH)D levels were only measured after cancer diagnosis. Two studies found an inverse association between 25(OH)D level and HNC risk, while two other prospective cohort studies demonstrated no connection between 25(OH)D and HNC risk. Several studies reported cancer patients to have significantly lower 25(OH)D levels than controls. Associations between 25(OH)D and prognosis and mortality were variable.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Summary<\/jats:title>\n                <jats:p>The link between vitamin D and HNC has so far only been investigated in a few observational, prospective, and case-control studies. Vitamin D deficiency may be more common in HNC patients than in the healthy population. There is no evidence for a causal relationship. Further studies are needed to evaluate whether low 25(OH)D concentrations play a role in the development or outcome of HNCs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11912-020-00996-7","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T14:06:13Z","timestamp":1605881173000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Vitamin D in Head and Neck Cancer: a Systematic Review"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0451-2404","authenticated-orcid":false,"given":"Antti","family":"M\u00e4kitie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iida","family":"Tuokkola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6ran","family":"Laurell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4547-001X","authenticated-orcid":false,"given":"Outi","family":"M\u00e4kitie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4784-0499","authenticated-orcid":false,"given":"Robert P.","family":"Takes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2689-3009","authenticated-orcid":false,"given":"Ewa","family":"Florek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Szyfter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4337-2758","authenticated-orcid":false,"given":"Cornelis F. M.","family":"Sier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfio","family":"Ferlito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,20]]},"reference":[{"issue":"6","key":"996_CR1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"996_CR2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hed.24589","volume":"39","author":"JH Ng","year":"2017","unstructured":"Ng JH, Iyer NG, Tan M, Edgren G. Changing epidemiology of oral squamous cell carcinoma of the tongue: a global study. Head Neck. 2017;39(2):297\u2013304.","journal-title":"Head Neck"},{"issue":"4","key":"996_CR3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.coms.2018.06.001","volume":"30","author":"N Cohen","year":"2018","unstructured":"Cohen N, Fedewa S, Chen AY. Epidemiology and demographics of the head and neck cancer population. Oral Maxillofac Surg Clin North Am. 2018;30(4):381\u201395.","journal-title":"Oral Maxillofac Surg Clin North Am"},{"issue":"3","key":"996_CR4","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"\u2022\u2022 Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266\u201381 This article provides a review on vitamin D metabolism and evidence for vitamin D status and various outcomes.","journal-title":"N Engl J Med"},{"issue":"12","key":"996_CR5","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nrd3318","volume":"9","author":"LA Plum","year":"2010","unstructured":"Plum LA, DeLuca HF. Vitamin D, disease and therapeutic opportunities. Nat Rev Drug Discov. 2010;9(12):941\u201355.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"996_CR6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/bies.10368","volume":"26","author":"R Lin","year":"2004","unstructured":"Lin R, White JH. The pleiotropic actions of vitamin D. Bioessays. 2004;26(1):21\u20138.","journal-title":"Bioessays."},{"issue":"11","key":"996_CR7","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1001\/archotol.133.11.1149","volume":"133","author":"JD Meier","year":"2007","unstructured":"Meier JD, Enepekides DJ, Poirier B, Bradley CA, Albala JS, Farwell DG. Treatment with 1-alpha,25-dihydroxyvitamin D3 (vitamin D3) to inhibit carcinogenesis in the hamster buccal pouch model. Arch Otolaryngol Head Neck Surg. 2007;133(11):1149\u201352.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"3","key":"996_CR8","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3892\/ijo.2016.3341","volume":"48","author":"Z Huang","year":"2016","unstructured":"Huang Z, Liu Y, Huang Z, Li H, Gan X, Shen Z. 1,25-Dihydroxyvitamin D3 alleviates salivary adenoid cystic carcinoma progression by suppressing GPX1 expression through the NF-kappaB pathway. Int J Oncol. 2016;48(3):1271\u20139.","journal-title":"Int J Oncol"},{"key":"996_CR9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jsbmb.2015.09.043","volume":"164","author":"T Shintani","year":"2016","unstructured":"Shintani T, Rosli SNZ, Takatsu F, Choon YF, Hayashido Y, Toratani S, et al. Eldecalcitol (ED-71), an analog of 1alpha,25-dihydroxyvitamin D3 as a potential anti-cancer agent for oral squamous cell carcinomas. J Steroid Biochem Mol Biol. 2016;164:79\u201384.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"6","key":"996_CR10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF00178289","volume":"253","author":"J Kornfehl","year":"1996","unstructured":"Kornfehl J, Formanek M, Temmel A, Knerer B, Willheim M. Antiproliferative effects of the biologically active metabolite of vitamin D3 (1,25 [OH]2 D3) on head and neck squamous cell carcinoma cell lines. Eur Arch Otorhinolaryngol. 1996;253(6):341\u20134.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"8","key":"996_CR11","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1600-0714.2006.00407.x","volume":"35","author":"C Gedlicka","year":"2006","unstructured":"Gedlicka C, Hager G, Weissenbock M, Gedlicka W, Knerer B, Kornfehl J, et al. 1,25(OH)2Vitamin D3 induces elevated expression of the cell cycle inhibitor p18 in a squamous cell carcinoma cell line of the head and neck. J Oral Pathol Med. 2006;35(8):472\u20138.","journal-title":"J Oral Pathol Med"},{"issue":"4","key":"996_CR12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0385-8146(03)00091-9","volume":"30","author":"K Satake","year":"2003","unstructured":"Satake K, Takagi E, Ishii A, Kato Y, Imagawa Y, Kimura Y, et al. Anti-tumor effect of vitamin A and D on head and neck squamous cell carcinoma. Auris Nasus Larynx. 2003;30(4):403\u201312.","journal-title":"Auris Nasus Larynx"},{"key":"996_CR13","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jsbmb.2013.09.002","volume":"138","author":"K Chiang","year":"2013","unstructured":"Chiang K, Yeh C, Hsu J, Chen L, Kuo S, Sun C, et al. MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0\/G1 with upregulation of p21 and p27 and downregulation of telomerase. J Steroid Biochem Mol Biol. 2013;138:427\u201334.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"996_CR14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/000164801300006353","volume":"121","author":"G Hager","year":"2001","unstructured":"Hager G, Formanek M, Gedlicka C, Thurnher D, Knerer B, Kornfehl J. 1,25(OH)2 vitamin D3 induces elevated expression of the cell cycle-regulating genes P21 and P27 in squamous carcinoma cell lines of the head and neck. Acta Otolaryngol (Stockh). 2001;121(1):103\u20139.","journal-title":"Acta Otolaryngol (Stockh)"},{"issue":"10","key":"996_CR15","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/jnci\/93.10.745","volume":"93","author":"J Prudencio","year":"2001","unstructured":"Prudencio J, Akutsu N, Benlimame N, Wang T, Bastien Y, Lin R, et al. Action of low calcemic 1alpha,25-dihydroxyvitamin D3 analogue EB1089 in head and neck squamous cell carcinoma. J Natl Cancer Inst. 2001;93(10):745\u201353.","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"996_CR16","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/s11626-014-9787-5","volume":"50","author":"SNZB Rosli","year":"2014","unstructured":"Rosli SNZB, Shintani T, Toratani S, Usui E, Okamoto T. 1alpha,25(OH)2D3 inhibits FGF-2 release from oral squamous cell carcinoma cells through down-regulation of HBp17\/FGFBP-1. In Vitro Cell Dev Biol Anim. 2014;50(9):802\u20136.","journal-title":"In Vitro Cell Dev Biol Anim"},{"issue":"9","key":"996_CR17","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1007\/s11626-017-0183-9","volume":"53","author":"T Shintani","year":"2017","unstructured":"Shintani T, Takatsu F, Rosli SNZ, Usui E, Hamada A, Sumi K, et al. Eldecalcitol (ED-71), an analog of 1alpha,25(OH)2D3, inhibits the growth of squamous cell carcinoma (SCC) cells in vitro and in vivo by down-regulating expression of heparin-binding protein 17\/fibroblast growth factor-binding protein-1 (HBp17\/FGFBP-1) and FGF-2. In Vitro Cell Dev Biol Anim. 2017;53(9):810\u20137.","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"996_CR18","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.2147\/DDDT.S115121","volume":"10","author":"S Yang","year":"2016","unstructured":"Yang S, Tsai C, Pan Y, Yeh C, Pang JS, Takano M, et al. MART-10, a newly synthesized vitamin D analog, represses metastatic potential of head and neck squamous carcinoma cells. Drug Des Devel Ther. 2016;10:1995\u20132002.","journal-title":"Drug Des Devel Ther"},{"issue":"7","key":"996_CR19","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/jnci\/djj101","volume":"98","author":"E Giovannucci","year":"2006","unstructured":"Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst. 2006;98(7):451\u20139.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"996_CR20","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/ijc.25439","volume":"128","author":"S Gandini","year":"2011","unstructured":"Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, Sneyd MJ, et al. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer. 2011;128(6):1414\u201324.","journal-title":"Int J Cancer"},{"issue":"6","key":"996_CR21","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.canep.2009.10.014","volume":"33","author":"L Yin","year":"2009","unstructured":"Yin L, Raum E, Haug U, Arndt V, Brenner H. Meta-analysis of longitudinal studies: serum vitamin D and prostate cancer risk. Cancer Epidemiol. 2009;33(6):435\u201345.","journal-title":"Cancer Epidemiol"},{"key":"996_CR22","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.critrevonc.2017.02.015","volume":"112","author":"MJ Duffy","year":"2017","unstructured":"Duffy MJ, Murray A, Synnott NC, O'Donovan N, Crown J. Vitamin D analogues: potential use in cancer treatment. Crit Rev Oncol Hematol. 2017;112:190\u20137.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6","key":"996_CR23","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11912-020-00929-4","volume":"22","author":"T Akutsu","year":"2020","unstructured":"Akutsu T, Kitamura H, Himeiwa S, Kitada S, Akasu T, Urashima M. Vitamin D and cancer survival: does vitamin D supplementation improve the survival of patients with cancer? Curr Oncol Rep. 2020;22(6):62.","journal-title":"Curr Oncol Rep"},{"issue":"4","key":"996_CR24","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264\u20139.","journal-title":"Ann Intern Med"},{"key":"996_CR25","unstructured":"Viswanathan M, Berkman ND, Dryden BM. Assessing risk of bias and confounding in observational studies of interventions or exposures: further development of the RTI Item Bank [Internet]. 2013; Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK154456\/. Accessed 25.3., 2020."},{"key":"996_CR26","doi-asserted-by":"crossref","first-page":"36017","DOI":"10.1038\/srep36017","volume":"6","author":"A Fanidi","year":"2016","unstructured":"\u2022 Fanidi A, Muller DC, Midttun O, Ueland PM, Vollset SE, Relton C, et al. Circulating vitamin D in relation to cancer incidence and survival of the head and neck and oesophagus in the EPIC cohort. Sci Rep. 2016;6:36017 This European Prospective Investigation into Cancer and Nutrition (EPIC) study is a prospective nested case-control study demonstrating that doubling of 25(OH)D plasma levels significantly reduced the cancer risk in the HNC patients (n=350) compared with the controls (n=940).","journal-title":"Sci Rep"},{"issue":"5","key":"996_CR27","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1373\/clinchem.2012.201939","volume":"59","author":"S Afzal","year":"2013","unstructured":"Afzal S, Bojesen SE, Nordestgaard BG. Low plasma 25-hydroxyvitamin D and risk of tobacco-related cancer. Clin Chem. 2013;59(5):771\u201380.","journal-title":"Clin Chem"},{"issue":"7","key":"996_CR28","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1158\/1055-9965.EPI-14-0007","volume":"23","author":"T Skaaby","year":"2014","unstructured":"Skaaby T, Husemoen LLN, Thuesen BH, Pisinger C, Jorgensen T, Roswall N, et al. Prospective population-based study of the association between serum 25-hydroxyvitamin-D levels and the incidence of specific types of cancer. Cancer Epidemiol Biomark Prev. 2014;23(7):1220\u20139.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"6","key":"996_CR29","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1158\/1055-9965.EPI-11-0153","volume":"20","author":"H Arem","year":"2011","unstructured":"\u2022 Arem H, Weinstein SJ, Horst RL, Virtamo J, Yu K, Albanes D, et al. Serum 25-hydroxyvitamin D and risk of oropharynx and larynx cancers in Finnish men. Cancer Epidemiol Biomark Prev. 2011;20(6):1178\u201384 A prospective, nested case-control study (340 vs 340) demonstrating no connection between 25(OH)D levels and HNC risk.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"11","key":"996_CR30","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s10654-018-0428-2","volume":"33","author":"SJ Weinstein","year":"2018","unstructured":"\u2022 Weinstein SJ, Mondul AM, Yu K, Layne TM, Abnet CC, Freedman ND, et al. Circulating 25-hydroxyvitamin D up to 3 decades prior to diagnosis in relation to overall and organ-specific cancer survival. Eur J Epidemiol. 2018;33(11):1087\u201399 A large prospective study including 398 HNC patients showed no connection between 25(OH)D levels and HNC mortality.","journal-title":"Eur J Epidemiol"},{"issue":"10","key":"996_CR31","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1002\/hed.21954","volume":"34","author":"H Orell-Kotikangas","year":"2012","unstructured":"Orell-Kotikangas H, Schwab U, \u00d6sterlund P, Saarilahti K, M\u00e4kitie O, M\u00e4kitie AA. High prevalence of vitamin D insufficiency in patients with head and neck cancer at diagnosis. Head Neck. 2012;34(10):1450\u20135.","journal-title":"Head Neck"},{"issue":"2","key":"996_CR32","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4317\/medoral.20368","volume":"20","author":"M Grimm","year":"2015","unstructured":"Grimm M, Cetindis M, Biegner T, Lehman M, Munz A, Teriete P, et al. Serum vitamin D levels of patients with oral squamous cell carcinoma (OSCC) and expression of vitamin D receptor in oral precancerous lesions and OSCC. Med Oral Patol Oral Cir Bucal. 2015;20(2):188.","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"996_CR33","doi-asserted-by":"crossref","unstructured":"Nejatinamini S, Debenham BJ, Clugston RD, Mawani A, Parliament M, Wismer WV, et al. Poor vitamin status is associated with skeletal muscle loss and mucositis in head and neck cancer patients. Nutrients. 2018;10(9):1236.","DOI":"10.3390\/nu10091236"},{"issue":"3","key":"996_CR34","first-page":"145","volume":"21","author":"A Anand","year":"2017","unstructured":"Anand A, Singh S, Sonkar AA, Husain N, Singh KR, Kushwaha JK. Expression of vitamin D receptor and vitamin D status in patients with oral neoplasms and effect of vitamin D supplementation on quality of life in advanced cancer treatment. Contemp Oncol. 2017;21(3):145\u201351.","journal-title":"Contemp Oncol"},{"issue":"4","key":"996_CR35","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4103\/1012-5574.192550","volume":"32","author":"BE Mostafa","year":"2016","unstructured":"Mostafa BE, Abdelmageed HM, El-Begermy MM, Taha MS, Hamdy TA, Omran A, et al. Value of vitamin D assessment in patients with head and neck squamous cell cancer before treatment. Egypt J Otolaryngol. 2016;32(4):279\u201386.","journal-title":"Egypt J Otolaryngol"},{"issue":"9","key":"996_CR36","doi-asserted-by":"crossref","first-page":"e1476817","DOI":"10.1080\/2162402X.2018.1476817","volume":"7","author":"F Bochen","year":"2018","unstructured":"Bochen F, Balensiefer B, Korner S, Bittenbring JT, Neumann F, Koch A, et al. Vitamin D deficiency in head and neck cancer patients - prevalence, prognostic value and impact on immune function. Oncoimmunology. 2018;7(9):e1476817.","journal-title":"Oncoimmunology."},{"issue":"8","key":"996_CR37","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00405-010-1481-y","volume":"268","author":"M Gugatschka","year":"2011","unstructured":"Gugatschka M, Kiesler K, Obermayer-Pietsch B, Groselj-Strele A, Griesbacher A, Friedrich G. Vitamin D status is associated with disease-free survival and overall survival time in patients with squamous cell carcinoma of the upper aerodigestive tract. Eur Arch Otorhinolaryngol. 2011;268(8):1201\u20134.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"7","key":"996_CR38","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/ijc.25496","volume":"128","author":"F Meyer","year":"2011","unstructured":"Meyer F, Liu G, Douville P, Samson E, Xu W, Adjei A, et al. Dietary vitamin D intake and serum 25-hydroxyvitamin D level in relation to disease outcomes in head and neck cancer patients. Int J Cancer. 2011;128(7):1741\u20136.","journal-title":"Int J Cancer"},{"issue":"6","key":"996_CR39","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/ajcn\/85.6.1586","volume":"85","author":"JM Lappe","year":"2007","unstructured":"Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. 2007;85(6):1586\u201391.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"996_CR40","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa1809944","volume":"380","author":"JE Manson","year":"2019","unstructured":"Manson JE, Cook NR, Lee I, Christen W, Bassuk SS, Mora S, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2019;380(1):33\u201344.","journal-title":"N Engl J Med"},{"key":"996_CR41","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1136\/bmj.l4673","volume":"366","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Fang F, Tang J, Jia L, Feng Y, Xu P, et al. Association between vitamin D supplementation and mortality: systematic review and meta-analysis. BMJ. 2019;366:4673.","journal-title":"BMJ."},{"issue":"5","key":"996_CR42","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/annonc\/mdz059","volume":"30","author":"N Keum","year":"2019","unstructured":"Keum N, Lee DH, Greenwood DC, Manson JE, Giovannucci E. Vitamin D supplementation and total cancer incidence and mortality: a meta-analysis of randomized controlled trials. Ann Oncol. 2019;30(5):733\u201343.","journal-title":"Ann Oncol"},{"issue":"7","key":"996_CR43","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.humimm.2010.04.008","volume":"71","author":"JE Walsh","year":"2010","unstructured":"Walsh JE, Clark A, Day TA, Gillespie MB, Young MRI. Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma. Hum Immunol. 2010;71(7):659\u201365.","journal-title":"Hum Immunol"},{"issue":"5","key":"996_CR44","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00262-003-0459-7","volume":"53","author":"DMR Lathers","year":"2004","unstructured":"Lathers DMR, Clark JI, Achille NJ, Young MRI. Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3. Cancer Immunol Immunother. 2004;53(5):422\u201330.","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"996_CR45","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.cyto.2012.03.002","volume":"58","author":"DD Walker","year":"2012","unstructured":"Walker DD, Reeves TD, de Costa A, Schuyler C, Young MRI. Immunological modulation by 1alpha,25-dihydroxyvitamin D3 in patients with squamous cell carcinoma of the head and neck. Cytokine. 2012;58(3):448\u201354.","journal-title":"Cytokine."}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-020-00996-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11912-020-00996-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-020-00996-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T17:08:42Z","timestamp":1610816922000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11912-020-00996-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,20]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["996"],"URL":"https:\/\/doi.org\/10.1007\/s11912-020-00996-7","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,20]]},"assertion":[{"value":"5 November 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}}],"article-number":"5"}}